FDA Approved: OXTELLAR XR — Original Application (Supernus Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approves OXTELLAR XR (oxcarbazepine) from Supernus Pharmaceuticals as an original application for an extended-release formulation to treat seizures.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy
• Partial-onset Seizures

Drugs mentioned

• OXTELLAR XR (oxcarbazepine)

Snippet

ORIG AP for OXTELLAR XR (OXCARBAZEPINE)